Not applicableAvailableNCT07748299What this trial is testingNuvOx Expanded AccessWho this might be right forGlioblastomaRespiratory Distress SyndromIschemic Stroke+1 more NuvOx LLC
Not applicableStudy completedNCT02663232What this trial is testingStudy to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic MelanomaWho this might be right forMetastatic Cancers Hoffmann-La Roche 264
Testing effectiveness (Phase 2)Looking for participantsNCT07070232What this trial is testingA Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsWho this might be right forAdvanced Solid Tumor BioNTech SE 1,438
Not applicableEnded earlyNCT00651716What this trial is testingT Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Vanderbilt-Ingram Cancer Center 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT04645680What this trial is testingDiet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving ImmunotherapyWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+7 more M.D. Anderson Cancer Center 50
Early research (Phase 1)Study completedNCT02027961What this trial is testingPhase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib AloneWho this might be right forMelanoma MedImmune LLC 68
Early research (Phase 1)Ended earlyNCT01700569What this trial is testingPhase-1 Study of Folinic Acid to Modulate MGMT Gene in GlioblastomaWho this might be right forGrade IV AstrocytomaGlioblastoma Institut Cancerologie de l'Ouest 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03647163What this trial is testingPh I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid TumorsWho this might be right forSolid TumorNon Small Cell Lung CancerNeuroendocrine Carcinoma+1 more Vyriad, Inc. 33
Early research (Phase 1)Looking for participantsNCT07492316What this trial is testingRNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)Who this might be right forRecurrent Medulloblastoma University of Florida 24
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06763965What this trial is testingEvaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.Who this might be right forRecurrent High-grade Glioma Beijing Bio-Targeting Therapeutics Technology Co., Ltd 30
Not applicableEnded earlyNCT03709771What this trial is testingNovel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular DiseaseWho this might be right forRenal Cell CarcinomaHypertensionMelanoma+1 more Vanderbilt University Medical Center 2
Early research (Phase 1)Study completedNCT02022644What this trial is testingStudy of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade GliomaWho this might be right forHigh Grade Glioma University of California, San Francisco 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05859334What this trial is testingTesting the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following TreatmentWho this might be right forRecurrent GliomaRecurrent WHO Grade 2 GliomaRecurrent WHO Grade 3 Glioma+1 more National Cancer Institute (NCI) 30
Not applicableActive Not RecruitingNCT07531121What this trial is testingCtDNA for Risk Stratification in MelanomaWho this might be right forMelanoma (Skin Cancer) Herlev and Gentofte Hospital 296
Testing effectiveness (Phase 2)Study completedNCT00019214What this trial is testingVaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT01264081What this trial is testingLapatinib in Stage IV Melanoma With ERBB4 MutationsWho this might be right forMalignant Melanoma National Cancer Institute (NCI) 34
Early research (Phase 1)Looking for participantsNCT07193628What this trial is testingB7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory GlioblastomaWho this might be right forRefractory GlioblastomaRecurrent Glioblastoma Second Affiliated Hospital, Zhejiang University, School of Medicine 14
Very early researchActive Not RecruitingNCT05634707What this trial is testingEvaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)Who this might be right forPrimary Brain TumorBrain Tumor, Recurrent Duke University 10
Early research (Phase 1)Study completedNCT01460134What this trial is testingCDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersWho this might be right forCD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more Celldex Therapeutics 90
Not applicableLooking for participantsNCT05768087What this trial is testingEscalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma PatientsWho this might be right forGlioblastoma University of Aarhus 36